All Articles

The Humanoids Summit's expansion to Seoul is more than a conference; it's a marker of South Korea's calculated bid for dominance in a new industrial era.

VERAXA Biotech is betting its future on its proprietary BiTAC technology, a strategic pivot that sharpens its focus amid a volatile market for cancer therapies.

With its new PD2732U, BenQ makes a strategic play for the professional creative market, blending top-tier color accuracy with aggressive workflow integration.

A new collaboration between beauty brand MONCLOS and lifestyle icon BALANSA isn't just a product launch; it's a signal of K-beauty's strategic pivot.

LibertyStream is commissioning an automated system that turns oilfield wastewater into lithium, a pivotal step in repurposing old energy infrastructure for new.

CHFA's new 'Greenhouse' program aims to launch Canada's next wellness stars. Is this structured ecosystem the key to sustainable growth in a booming market?

A Nasdaq firm boasts impressive crypto yields and a vision to audit AI. But beneath the stable facade, it's built on a token that has lost 98% of its value.

Initial assays from El Zanjon show no gold but reveal silver anomalies and key geological clues, suggesting Targa is on the trail of a major system.

The Hong Kong Jockey Club is fusing horse racing with the World Cup. We uncover the quiet operational innovation behind this global entertainment spectacle.

A massive reinsurance deal isn't just about money; it's about strategy. Unum is shedding risky policies, and Fortitude Re is pioneering a new risk model.

A new academy is offering Hong Kong professionals a complex but lucrative path to dual legal practice. Is this the key to unlocking the Greater Bay Area?

In a savvy move, Coast Copper divests a gold asset to Talisker, showcasing a capital strategy that could serve as a model for the junior mining sector.

A US med-tech firm just invested in a German airline. The goal: to build a private air network for organs and revolutionize a broken transplant system.

Exceptional new drill results confirm a richer, deeper PGM deposit, while a strategic pivot into copper-gold exploration reveals a larger vision for Bravo.

Australian biotech Immuron hires a top dealmaker to land a partner for its novel C. diff therapy. The goal: secure funding and unlock a potential $400M market.

Phoebe Greenberg's two-decade mission culminates in a new Montréal institution, blending heritage with innovation through a powerful public-private partnership.

Englobe's acquisition of Pluritec isn't just a merger; it's a calculated move to dominate Québec's booming infrastructure market. Here's how.

After a Health Canada-mandated pause, LSL's Steri-Med is near full remediation. This is more than a fix—it’s a calculated play for North American market leadership.

With its AUM soaring to $600B, Mubadala Capital is making a bold play in private credit, signaling a new era for sovereign-backed asset managers.

Buoyed by stellar well results, Logan Energy is boosting its 2026 spending and output targets, a confident bet on its Montney assets amid market uncertainty.